Hyderabad Telangana, India

Suresh Babu Radhakrishnan

This inventor holds 1 USPTO granted patent. Top assignee: Laurus Labs Private Limited. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suresh Babu Radhakrishnan. Retrieved from https://idiyas.com/inventor/suresh-babu-radhakrishnan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suresh Babu Radhakrishnan: Innovator in Pharmaceutical Chemistry

Introduction

Suresh Babu Radhakrishnan is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on nilotinib hydrochloride.

Latest Patents

Suresh holds a patent for the "Crystalline form of nilotinib hydrochloride, process for its preparation and pharmaceutical composition containing the same." This invention relates to a novel crystalline form of nilotinib hydrochloride, detailing the process for its preparation and the pharmaceutical composition that includes this compound. He has 1 patent to his name.

Career Highlights

Suresh Babu Radhakrishnan is currently associated with Laurus Labs Private Limited, where he continues to advance his research and development efforts in pharmaceuticals. His work has been instrumental in enhancing the efficacy and stability of pharmaceutical formulations.

Collaborations

Some of his notable coworkers include Ram Thaimattam and Nageswara Rao Regandla, who have collaborated with him on various projects within the pharmaceutical sector.

Conclusion

Suresh Babu Radhakrishnan exemplifies the spirit of innovation in the pharmaceutical industry, contributing valuable advancements that benefit healthcare. His work continues to inspire future developments in drug formulation and delivery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…